Allergan To Close Five Manufacturing Plants By 2001 As Part Of Restructuring
This article was originally published in The Gray Sheet
Allergan will close half of its 10 global manufacturing facilities over the next three years as part of a corporate reorganization announced Sept. 15.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.